"GTP Phosphohydrolases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzymes that hydrolyze GTP to GDP. EC 3.6.1.-.
| Descriptor ID |
D020558
|
| MeSH Number(s) |
D08.811.277.040.330
|
| Concept/Terms |
GTP Phosphohydrolases- GTP Phosphohydrolases
- Phosphohydrolases, GTP
- GTPase
- GTPases
- Guanosinetriphosphatases
- Guanosine Triphosphate Phosphohydrolases
- Phosphohydrolases, Guanosine Triphosphate
- Triphosphate Phosphohydrolases, Guanosine
- GTP Phosphohydrolase
- Phosphohydrolase, GTP
|
Below are MeSH descriptors whose meaning is more general than "GTP Phosphohydrolases".
Below are MeSH descriptors whose meaning is more specific than "GTP Phosphohydrolases".
This graph shows the total number of publications written about "GTP Phosphohydrolases" by people in this website by year, and whether "GTP Phosphohydrolases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1997 | 3 | 0 | 3 |
| 1998 | 4 | 3 | 7 |
| 1999 | 3 | 1 | 4 |
| 2000 | 3 | 1 | 4 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 2 | 3 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 1 | 2 | 3 |
| 2007 | 1 | 1 | 2 |
| 2009 | 3 | 1 | 4 |
| 2010 | 1 | 0 | 1 |
| 2011 | 3 | 0 | 3 |
| 2012 | 1 | 0 | 1 |
| 2013 | 3 | 3 | 6 |
| 2014 | 2 | 5 | 7 |
| 2015 | 3 | 4 | 7 |
| 2016 | 5 | 0 | 5 |
| 2017 | 3 | 0 | 3 |
| 2018 | 5 | 2 | 7 |
| 2019 | 4 | 2 | 6 |
| 2020 | 0 | 2 | 2 |
| 2021 | 2 | 0 | 2 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 2 | 2 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "GTP Phosphohydrolases" by people in Profiles.
-
Oncogenic NRAS Mutation in Incipient Sarcomatous Transformation of Cystic Nephroma From a Patient With DICER1-Related Tumor Predisposition Syndrome. Pediatr Blood Cancer. 2026 Feb; 73(2):e70068.
-
Reprogramming tumour-associated macrophages to outcompete cancer cells. Nature. 2023 07; 619(7970):616-623.
-
Leukocytosis and Splenomegaly in a Neonate With NRAS Mutation. Clin Pediatr (Phila). 2024 May; 63(4):451-455.
-
RbgA ensures the correct timing in the maturation of the 50S subunits functional sites. Nucleic Acids Res. 2022 10 28; 50(19):10801-10816.
-
Elevated NRAS expression during DCIS is a potential driver for progression to basal-like properties and local invasiveness. Breast Cancer Res. 2022 10 18; 24(1):68.
-
Computational investigation to identify potent inhibitors of the GTPase-Kirsten RAt sarcoma virus (K-Ras) mutants G12C and G12D. Comput Biol Med. 2021 12; 139:104946.
-
Neurocutaneous Melanocytosis and Leptomeningeal Melanoma. J Pediatr Hematol Oncol. 2021 03 01; 43(2):e195-e197.
-
Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study. Brain. 2020 12 01; 143(12):3589-3602.
-
Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity. Nat Commun. 2020 10 16; 11(1):5259.
-
Structural consequences of the interaction of RbgA with a 50S ribosomal subunit assembly intermediate. Nucleic Acids Res. 2019 11 04; 47(19):10414-10425.